All of the doses will be distributed through COVAX — the global entity that is working to ensure equitable access to COVID testing and vaccines — and will be given to 92 low- and middle-income countries and the African Union. Keep Reading
The British government has on December 2 accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency to approve Pfizer/BioNTech’s COVID-19 vaccine for use. Keep Reading
Scientists Ugur Sahin and Ozlem Tureci have dedicated their lives to the field of oncology and infectious diseases, and spent years pioneering personalized immunotherapy treatments for cancer. Keep Reading
Pfizer says the first set of results from the Phase 3 vaccine trial provides the initial evidence of the vaccine’s ability to prevent COVID-19. Keep Reading